vs

Side-by-side financial comparison of ALBANY INTERNATIONAL CORP (AIN) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.

Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($336.6M vs $321.2M, roughly 1.0× ALBANY INTERNATIONAL CORP). ALBANY INTERNATIONAL CORP runs the higher net margin — 4.3% vs 4.0%, a 0.3% gap on every dollar of revenue. On growth, ALBANY INTERNATIONAL CORP posted the faster year-over-year revenue change (12.0% vs 2.2%).

Albany International Corp is a global advanced materials and industrial technology company. It operates two core segments: Machine Clothing producing custom engineered fabrics for paper and other industrial manufacturing processes, and Engineered Composites developing high-performance composite components primarily for the aerospace and defense sectors, serving customers across North America, Europe, Asia and other global regions.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

AIN vs GRDN — Head-to-Head

Bigger by revenue
GRDN
GRDN
1.0× larger
GRDN
$336.6M
$321.2M
AIN
Growing faster (revenue YoY)
AIN
AIN
+9.7% gap
AIN
12.0%
2.2%
GRDN
Higher net margin
AIN
AIN
0.3% more per $
AIN
4.3%
4.0%
GRDN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AIN
AIN
GRDN
GRDN
Revenue
$321.2M
$336.6M
Net Profit
$13.9M
$13.5M
Gross Margin
31.1%
22.7%
Operating Margin
9.3%
5.3%
Net Margin
4.3%
4.0%
Revenue YoY
12.0%
2.2%
Net Profit YoY
-21.5%
46.1%
EPS (diluted)
$0.56
$0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIN
AIN
GRDN
GRDN
Q1 26
$336.6M
Q4 25
$321.2M
$397.6M
Q3 25
$261.4M
$377.4M
Q2 25
$311.4M
$344.3M
Q1 25
$288.8M
$329.3M
Q4 24
$286.9M
Q3 24
$298.4M
$314.4M
Q2 24
$332.0M
Net Profit
AIN
AIN
GRDN
GRDN
Q1 26
$13.5M
Q4 25
$13.9M
$20.9M
Q3 25
$-97.8M
$9.8M
Q2 25
$9.2M
$9.0M
Q1 25
$17.4M
$9.4M
Q4 24
$17.7M
Q3 24
$18.0M
$-122.0M
Q2 24
$24.6M
Gross Margin
AIN
AIN
GRDN
GRDN
Q1 26
22.7%
Q4 25
31.1%
21.5%
Q3 25
-19.1%
19.8%
Q2 25
31.3%
19.8%
Q1 25
33.4%
19.5%
Q4 24
31.5%
Q3 24
30.3%
19.4%
Q2 24
33.9%
Operating Margin
AIN
AIN
GRDN
GRDN
Q1 26
5.3%
Q4 25
9.3%
7.7%
Q3 25
-44.6%
4.3%
Q2 25
7.2%
3.7%
Q1 25
9.8%
3.9%
Q4 24
8.5%
Q3 24
8.4%
-33.3%
Q2 24
12.9%
Net Margin
AIN
AIN
GRDN
GRDN
Q1 26
4.0%
Q4 25
4.3%
5.3%
Q3 25
-37.4%
2.6%
Q2 25
2.9%
2.6%
Q1 25
6.0%
2.9%
Q4 24
6.2%
Q3 24
6.0%
-38.8%
Q2 24
7.4%
EPS (diluted)
AIN
AIN
GRDN
GRDN
Q1 26
$0.21
Q4 25
$0.56
Q3 25
$-3.37
Q2 25
$0.31
Q1 25
$0.56
Q4 24
$0.57
Q3 24
$0.57
Q2 24
$0.79

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIN
AIN
GRDN
GRDN
Cash + ST InvestmentsLiquidity on hand
$112.3M
$64.9M
Total DebtLower is stronger
$455.7M
Stockholders' EquityBook value
$726.2M
$232.4M
Total Assets
$1.7B
$426.9M
Debt / EquityLower = less leverage
0.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIN
AIN
GRDN
GRDN
Q1 26
$64.9M
Q4 25
$112.3M
$65.6M
Q3 25
$108.3M
$36.5M
Q2 25
$106.7M
$18.8M
Q1 25
$119.4M
$14.0M
Q4 24
$115.3M
Q3 24
$127.2M
$37.2M
Q2 24
$116.4M
Total Debt
AIN
AIN
GRDN
GRDN
Q1 26
Q4 25
$455.7M
$0
Q3 25
$480.6M
Q2 25
$444.7M
Q1 25
$416.4M
Q4 24
$318.5M
Q3 24
$362.2M
$34.3M
Q2 24
$377.1M
Stockholders' Equity
AIN
AIN
GRDN
GRDN
Q1 26
$232.4M
Q4 25
$726.2M
$217.9M
Q3 25
$739.3M
$195.5M
Q2 25
$888.6M
$179.7M
Q1 25
$900.0M
$163.2M
Q4 24
$943.5M
Q3 24
$991.0M
$133.9M
Q2 24
$967.5M
Total Assets
AIN
AIN
GRDN
GRDN
Q1 26
$426.9M
Q4 25
$1.7B
$412.7M
Q3 25
$1.7B
$390.0M
Q2 25
$1.7B
$356.3M
Q1 25
$1.7B
$334.0M
Q4 24
$1.6B
Q3 24
$1.8B
$348.0M
Q2 24
$1.8B
Debt / Equity
AIN
AIN
GRDN
GRDN
Q1 26
Q4 25
0.63×
0.00×
Q3 25
0.65×
Q2 25
0.50×
Q1 25
0.46×
Q4 24
0.34×
Q3 24
0.37×
0.26×
Q2 24
0.39×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIN
AIN
GRDN
GRDN
Operating Cash FlowLast quarter
$73.7M
$6.1M
Free Cash FlowOCF − Capex
$51.4M
FCF MarginFCF / Revenue
16.0%
Capex IntensityCapex / Revenue
6.9%
Cash ConversionOCF / Net Profit
5.31×
0.45×
TTM Free Cash FlowTrailing 4 quarters
$82.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIN
AIN
GRDN
GRDN
Q1 26
$6.1M
Q4 25
$73.7M
$34.6M
Q3 25
$43.9M
$28.2M
Q2 25
$32.7M
$19.9M
Q1 25
$2.1M
$17.6M
Q4 24
$78.5M
Q3 24
$47.0M
Q2 24
$83.4M
Free Cash Flow
AIN
AIN
GRDN
GRDN
Q1 26
Q4 25
$51.4M
Q3 25
$25.9M
$24.2M
Q2 25
$18.8M
Q1 25
$-13.5M
Q4 24
$60.2M
Q3 24
$31.6M
Q2 24
$63.6M
FCF Margin
AIN
AIN
GRDN
GRDN
Q1 26
Q4 25
16.0%
Q3 25
9.9%
6.4%
Q2 25
6.0%
Q1 25
-4.7%
Q4 24
21.0%
Q3 24
10.6%
Q2 24
19.2%
Capex Intensity
AIN
AIN
GRDN
GRDN
Q1 26
Q4 25
6.9%
Q3 25
6.9%
1.1%
Q2 25
4.5%
Q1 25
5.4%
Q4 24
6.4%
Q3 24
5.2%
Q2 24
6.0%
Cash Conversion
AIN
AIN
GRDN
GRDN
Q1 26
0.45×
Q4 25
5.31×
1.65×
Q3 25
2.87×
Q2 25
3.56×
2.21×
Q1 25
0.12×
1.86×
Q4 24
4.44×
Q3 24
2.61×
Q2 24
3.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AIN
AIN

Transferred At Point In Time$176.5M55%
Engineered Composites Other$99.3M31%
Engineered Composites ASC$44.5M14%
Transferred Over Time$1.0M0%

GRDN
GRDN

Segment breakdown not available.

Related Comparisons